RBC Capital initiated coverage on SteadyMed (NASDAQ: STDY) with an Outperform rating and a price target of $18.00.Analyst Adnan Butt ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE